Q4 2024 Management View Richard Paulson, President and CEO, highlighted the company's achievements in 2024, including meeting financial guidance, executing cost reduction initiatives, and advancing ...

FTC Chair Andrew Ferguson sent a memo to agency staff on Tuesday clarifying that the Biden-era guidelines will remain in ...

The cuts hit the FDA’s medical device center particularly hard, impacting product reviewers and researchers of AI-enabled medical technology. Notably, the center has a strained relationship with one ...

WASHINGTON — Processed food companies and federal nutrition guidelines and programs could be in the crosshairs of President Donald Trump’s new Make America Healthy Again (MAHA) Commission, according ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for ...

The progression of evidence has marched forward from studies showing a reduction in salt associated with lower blood pressure ...

Industry experts and providers are worried layoffs at the Health and Human Services Department could slow down prior ...

About half of U.S. adults have high blood pressure and too few have it under control. Now some patients who've tried ...

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for active ...

While the FDA’s diversity guidance for clinical trials has been temporarily restored, the page it is housed on now carries a ...

A core group of so-called disease detectives, who track outbreaks, was apparently spared. But other young researchers are out ...

This finding is especially interesting because the same drug was less effective at lowering blood sugar levels in older ...